Target intelligence / Profile preview

Hepatitis C virus nonstructural proteins (HCV NS proteins)

Target
HCV NS proteins
Molecular classification
Enzyme (e.g., NS3 serine protease, NS3 helicase, NS5B RNA-dependent RNA polymerase), Viroporin (p7), Cysteine protease (NS2), Membrane-associated protein (NS4B, NS5A), Other (organizer proteins for viral assembly, e.g., NS2)
01

Overview

Hepatitis C virus nonstructural proteins are a set of viral proteins produced during HCV infection that play essential roles in RNA genome replication, proteolytic processing of the viral polyprotein, and the assembly of new infectious virus particles. These proteins are generally classified as enzymes (such as proteases, helicases, and polymerases) or membrane-associated proteins that organize and facilitate the replication complex within specialized cytoplasmic membrane structures. They are intracellular targets and do not form part of the virus particle itself. Therapeutic targeting of these molecules with direct-acting antiviral drugs has revolutionized HCV treatment by achieving robust viral suppression and cure rates.

Other names
HCV NS proteinsHepatitis C virus non-structural proteinsNS2, NS3, NS4A, NS4B, NS5A, NS5B, p7 (individual protein aliases)
02

Mechanism of action

Inhibition of NS3/4A protease blocks viral polyprotein processing and replication NS5A inhibitors disrupt organization of replication complexes and viral assembly NS5B inhibitors directly inhibit the RNA-dependent RNA polymerase activity and block viral RNA synthesis

03

Biological functions

Viral genome replication (NS3–NS5B)Proteolytic processing of the viral polyprotein (NS2, NS3/4A)RNA helicase activity (NS3)RNA polymerase activity (NS5B)Assembly of infectious viral particles (NS2, p7, NS3, NS5A, NS5B)Membrane rearrangement for viral replication (NS4A, NS4B, NS5A)Interference with host antiviral responses (NS5A)
04

Disease associations

Infection (central to HCV pathogenesis)Liver diseases, including chronic hepatitis, cirrhosis, hepatocellular carcinoma (indirect role via HCV pathogenicity)
05

Safety considerations

Rapid emergence of drug resistance (especially NS5A inhibitors due to low barrier to resistance)Drug-drug interactions for DAAsPotential for hepatotoxicity (challenge of treating advanced liver disease)
06

Interacting drugs

Direct-acting antivirals (DAAs)

3 more in the full profile.

07

Biomarkers

Resistance-associated substitutions (RASs) in NS5A and NS3/4A sequences used to monitor drug susceptibility and guide therapyHCV RNA levels (viral load, not direct NS protein measurement, but a proxy for replication activity)

Beyond the preview

Go deeper on Hepatitis C virus nonstructural proteins (HCV NS proteins).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatitis C virus nonstructural proteins (HCV NS proteins).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call